79 results
Page 3 of 4
8-K
EX-2.1
xgg t26pxo0ye4t58rz
10 Aug 21
Maravai Lifesciences Reports Second Quarter Financial Results and Updates 2021 Financial Guidance
4:18pm
10-Q
EX-31.2
ojbfu v54vcm
12 May 21
Quarterly report
4:26pm
10-Q
EX-31.1
h8jzr7f5
12 May 21
Quarterly report
4:26pm
10-Q
xve 9e9vg2tyynh8jt
12 May 21
Quarterly report
4:26pm
DEF 14A
hehxp9 79p
19 Apr 21
Definitive proxy
4:46pm
PRE 14A
li3jxuojrbw ct3muggj
9 Apr 21
Preliminary proxy
4:16pm
424B4
n1kj717yr1ki6m258
9 Apr 21
Prospectus supplement with pricing info
4:02pm
DRS
e6oy4 w3woo2yxo
25 Mar 21
Draft registration statement
12:00am
10-K
EX-31.1
zezffajuc9u uflt
22 Mar 21
Annual report
4:22pm
10-K
jeif 734cpjylov65
22 Mar 21
Annual report
4:22pm
10-K
EX-31.2
un61l
22 Mar 21
Annual report
4:22pm
8-K
EX-3.2
ebno2r4snfxuo7wsb
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
8-K
EX-10.1
d7s8v57 mmt
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
8-K
EX-4.1
ybxf76plw npbpxtjsy
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
8-K
EX-10.3
ix6gk f91m
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
424B4
zbe0x 84x
23 Nov 20
Prospectus supplement with pricing info
4:36pm